141.

Batskor IA, Timar M. The treatment of lead poisoning with CaEDTA per os. Egeszsegtudomany 5. 1961; 3:259-263. (2230) [Examinations have been carried out in order to determine whether the administration of CaEDTA proved to be suitable in the treatment of Pb poisoning and on the other hand whether the increased Pb excretion caused by the effect of CaEDTA could be used in determining the Pb exposure more exactly. On the basis of the examinations it has been established: With per os treatment (during 15-20 days, daily 3 x 1 g) favorable therapeutic results might be obtained and therefore the treatment seems to be indicated in all cases where intravenous or intramuscular treatment was not applicable. The increased urinary Pb excretion has not proved to be suitable for the exact determination of the exposure. The increase in the Pb excretion due to the effect of CaEDTA basically differs in range in the different Pb-poisoned individuals and those who are working in Pb exposure but have no poisoning. The degree of the increase of Pb excretion due to the effect of CaEDTA is determined by the state of poisoning and not by the degree of exposure. The examination of the Pb excretion due to the effect of CaEDTA can be used in the diagnosis of Pb poisoning.]

Gordon Research Institute / Reference Material

Gordon Research Institute    Dr. Garry F. Gordon MD DO MD(H)
600 N Beeline Hwy, Suite B, Payson, AZ 85541
Phone: 928-472-4263    Fax: 928-474-3819
Email Dr.Gordon